Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell crawled date : 2022 - 06 - 07 save search
AlloVir Reports Blinded, Preliminary, Phase 2 Data Supporting the Ongoing Study of Posoleucel, a Multi-Virus-Specific T Cell Therapy, for the Treatment of BK Viremia in Kidney Transplant Recipients
Published: 2022-06-07 (Crawled : 13:20) - biospace.com/
ALVR | $0.7505 1.13% 1.12% 340K
|
Health Technology
|
| O: -1.55%
H: 7.85%
C: 4.71%
treatment ongoing kidney
Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and Gene Editing for the Treatment of Cancer
Published: 2022-06-07 (Crawled : 12:00) - immatics.com
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: 3.69%
H: 4.66%
C: 2.45%
treatment research collaboration cancer
Kiromic BioPharma Significantly Expands Gamma Delta T cell Product Pipeline with New Sponsored Research Agreement
Published: 2022-06-07 (Crawled : 12:00) - biospace.com/
KRBP | $2.5 -90.21% 830
|
Health Technology
|
| O: 100.0%
H: 7.17%
C: -16.33%
biopharma research
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.